NCT06023511View on ClinicalTrials.gov

Safety and Efficacy of the MyokinE100 (CL-EMS Alpha) Device in Inducing Visible Muscle Contraction in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 22, 2023

Primary Completion Date

August 23, 2023

Study Completion Date

August 23, 2023

Conditions
ICU Acquired Weakness
Interventions
DEVICE

Electrical muscle stimulation

While study subjects are connected to standard ICU monitors, electrical muscle stimulation will be applied at the level of the quadriceps muscle to induce palpable or visible muscle contraction. (No control group or sham procedure in this study).

Trial Locations (1)

78701

Ascension Texas Clinical Education Center (CEC), Austin

Sponsors

Collaborators (1)

Ascension Health
All Listed Sponsors
collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

NIH

collaborator

University of Texas at Austin

OTHER

collaborator

Ascension Health

INDUSTRY

lead

Health Discovery Labs

INDUSTRY

NCT06023511 - Safety and Efficacy of the MyokinE100 (CL-EMS Alpha) Device in Inducing Visible Muscle Contraction in Healthy Volunteers | Biotech Hunter | Biotech Hunter